Nicolas Kluger1, Caroline Le Floc'h2, Margot Niore2, Veronique Delvigne2, Guénaële Le Dantec2, Charles Taieb3. 1. Dermatology, Venereology, Allergology, Skin and Allergies Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. 2. Direction Scientifique, Laboratoire La Roche Posay, Levallois Perret, France. 3. Patients Priority Department, European Market Maintenance Assessment [EMMA], Fontenay Sous Bois, France.
Efforts to curb the spread of the new coronavirus (SARS-CoV-2) have led to an unprecedented simultaneous containment of almost two-thirds of the world’s population. The excessive use of hand washing and hand disinfection has been associated with an increased incidence of irritant and allergic contact eczema in health care workers.1 Face masks and headgear worn tightly for prolonged hours are also responsible for various cutaneous conditions, such as contact allergies, irritation, friction dermatitis, abrasions and aggravation of chronic dermatoses.2 Some authors also suspect that chilblains (“COVID toes”), which were widely reported in spring 2020, could be related to the containment rather than to direct SARS-CoV-2 infection.3 In addition, sensitive skin is a frequent condition in Western countries, ranging from 26 to 57% of the population, depending on the country.4 Sensitive skin is defined by the occurrence of unpleasant sensations in response to stimuli that should not normally provoke such sensations. The causative factors of skin sensitivity include physical (heat, cold, wind, or ultraviolet radiation), chemical (cleansers, cosmetics, water, or pollutants), psychological (emotional change or stress), or hormonal (menstrual cycle) factors.4,5Perceived consequences of containment on skin conditions have not been addressed to date in large-sized populations and in individuals suffering from sensitive skin. We performed an international online survey on a representative sample of people over 18 years of age from five countries (Brazil, France, Russia, China and the United States). The data collection procedure was identical to that in previous studies.6–9 For each country, a representative sample of the adult general population aged ≥18 years was recruited using a stratified proportional sampling with replacement design. Based on a database with the e-mail addresses of Internet users in each country, who agreed to participate in surveys (Megabase, Kantar Health, New York, NY, USA), fixed quotas of subjects fulfilling predefined sociodemographic criteria were decided. These quotas were based on the following aspects: sex, age, socio-professional status and regional distribution, thereby ensuring accurate representation of the sample population. Proportional quota sampling was used to make the study population representative of each country. Each selected participant was contacted by e-mail. If contact was not achieved, another potential participant with the same characteristics was randomly selected. Each participant agreed to complete a digital questionnaire.A total of 11,100 individuals (2,000 each in Brazil, France and Russia, 3050 in China and 2050 in the United States) participated between April and May 2020.We first inquired about socio-demographics, sensitive skin, and self-reported changes observed during containment (dry skin, skin rash, redness, and itching). The second part addressed facial skin sensitivity. The subjects were requested to rate their skin as “very sensitive,” “sensitive,” “slightly sensitive,” or “not sensitive.” Subjects with “sensitive” or “very sensitive” skin were considered to belong to the “sensitive skin” group, and those having “not very sensitive” or “not sensitive at all” skin belonged to the “non sensitive skin” group, as previously published elsewhere.4,10–12We did not inquire whether respondents had been diagnosed with COVID-19. As this study did not involve any patient contact and was completely anonymous, approval from the ethical review board was not necessary.A total of 64% (n=7170) of the respondents reported that they complied with the containment procedures (Table 1), ranging from 39% in China to 85.3% in Brazil (Table 2).
Table 1
Characteristics of the Respondents
TotalN=11,100
MenN=5486 (49.4%)
WomenN=5614 (50.6%)
Fisher’s Exact Testp<0.05Men vs Women
Age group
18–24
1367 (12.3)
694 (12.6)
673 (24.3)
NS
25-34
2430 (21.9)
1214 (22.1)
1216 (43.3)
NS
35–44
2289 (20.6)
1126 (20.5)
1163 (40.7)
NS
45-54
2093 (18.9)
1036 (18.9)
1057 (37.3)
NS
55–64
1781 (16.0)
893 (16.3)
888 (31.7)
NS
65-74
1140 (10.3)
523 (9.5)
617 (20.3)
0.01
Residency
Large-sized city
6240 (56.2)
3084 (56.2)
3156 (56.2)
NS
Middle-sized city
3111 (28.0)
1546 (28.2)
1565 (27.9)
Outside the city
1746 (15.8)
856 (15.6)
893 (15.9)
Skin type
Dry
2529 (22.8)
1059 (19.3)
1470 (26.2)
<0.00001
Greasy
2770 (24.9)
1803 (32.9)
967 (17.2)
<0.00001
Mixed
3823 (34.4)
1407 (25.6)
2416 (43.0)
<0.00001
Normal
1978 (17.8)
1217 (22.2)
761 (13.6)
<0.00001
Sensitive skin
Yes (very sensitive or sensitive)
5063 (45.6)
2246 (40.9)
2817 (50.2)
<0.00001
Containment
Yes
7170 (64.6)
3365 (61.3)
3805 (67.8)
<0.00001
Skin modification due to containment
Yes
1500 (20.9)
560 (16.6)
940 (24.7)
<0.00001
Skin modification
Drier skin
667 (44.5)
212 (37.9)
455 (48.4)
0.00007
Greasier skin
405 (27.0)
182 (32.5)
223 (23.7)
0.000213
Skin rash
440 (29.3)
142 (25.4)
298 (31.7)
0.009
Redness
259 (17.3)
110 (19.6)
149 (15.8)
NS
Itch
368 (24.5)
154(27.5)
214 (22.8)
0.04
None of the above
166 (11.1)
53 (9.5)
113 (12.0)
NS
Containment
Sensitive skin
3410 (67.3)
1427 (63.5)
1983 (70.4)
<0.00001
No sensitive skin
3760 (62.3)
1938 (59.8)
1822 (65.1)
-
Skin modification
Sensitive skin
944 (27.7)
353 (24.7)
591 (29.8)
NS
No sensitive skin
556 (14.8)
207 (10.7)
349 (19.1)
-
Patients with sensitive skin
Drier skin
418 (44.3)
132 (37.4)
286 (48.4)
0.001
Greasier skin
255 (27.0)
122 (34.6)
133 (22.5)
0.00005
Skin rash
298 (31.6)
95 (26.9)
203 (34.3)
0.017
Redness
211 (22.3)
89 (25.2)
122 (20.6)
NS
Itch
265 (28.1)
113 (32.0)
152 (25.7)
0.037
None of the above
82 (8.7)
19 (5.4)
63 (10.7)
0.005
p<0.05 vs Patients with sensitive skin
Patients without sensitive skin
Drier skin
249 (44.8)
-
-
NS
Greasier skin
150 (27.0)
NS
Skin rash
142 (25.5)
0.013
Redness
48 (8.6)
<0.00001
Itch
103 (18.5)
0.00003
None of the above
84 (15.1)
0.00012
Abbreviation: NS, not significant.
Table 2
Detailed Characteristics of the Respondents by Country
BrazilN=2000
ChinaN=3050
FranceN=2000
RussiaN=2000
USN=2050
Sensitive skin
Yes (very sensitive or fairly sensitive)
732 (36.6)
1229 (40.3)
1040 (52)
1227 (61.3)
835 (40.7)
Containment
Yes
1706(85.3)
1190 (39)
1640 (82)
1323 (66.1)
1311 (63.9)
Skin modification due to containment
Yes
477 (28.0)
274 (23.0)
278 (17.5)
215 (16.2)
247 (18.8)
Skin modification
Drier skin
224 (47.0)
97 (35.4)
137 (47.7)
100 (46.5)
109 (44.1)
Greasier skin
140 (29.3)
103 (37.6)
50 (17.4)
53 (24.6) 70
59 (23.9)
Skin rash
149 (31.2)
54 (19.7)
87 (30.3)
(32.6)
80 (32.4)
Redness
69 (14.5)
56 (20.4)
39 (15.6)
46(21.4)
49 (19.8)
Itch
118 (24.7)
78 (28.5)
63 (21.9)
31 (14.4)
78 (31.6)
None of the above
43 (9.0)
32 (11.7)
39 (13.6)
20 (9.3)
32 (13.0)
Skin modification if
Sensitive skin
250 (38.9)
167 (33.7)
196 (22.4)
162 (19.8)
169 (29.2)
No sensitive skin
227 (21.3)
107 (15.4)
91 (11.9)
53 (10.5)
78 (10.7)
Patients with sensitive skin
Drier skin
117 (46.8)
66 (39.5)
92 (46.9)
72 (44.4)
71 (42.0)
Greasier skin
75 (30)
61 (36.5)
34 (17.3)
41 (25.3)
44 (26.0)
Skin rash
82 (32.8)
32 (19.2)
62 (31.6)
58 (35.8)
64 (37.9)
Redness
48 (19.2)
44 (26.3)
36 (18.4)
41 (25.3)
42 (24.8)
Itch
66 (26.4)
60 (35.9)
52 (26.5)
27 (16.7)
60 (35.5)
None of the above
15 (6.0)
13 (7.8)
25 (12.8)
14 (8.6)
15 (8.9)
Patients without sensitive skin
Drier skin
107 (47.1)
31 (29.0)
45 (49.4)
28 (52.8)
38 (48.7)
Greasier skin
65 (28.6)
42 (39.2)
16 (17.6)
12 (22.6)
15 (19.2)
Skin rash
67 (29.5)
22 (20.6)
25 (27.5)
12 (22.6)
16 (20.5)
Redness
21 (9.2)
12 (11.2)
3 (3.3)
5 (9.4)
7 (9.0)
Itch
52 (22.9)
18 (16.8)
11 (12.1)
4 (7.5)
18 (23.1)
None of the above
28 (12.3)
19 (17.8)
14 (15.4)
6 (11.3)
17 (21.8)
Characteristics of the RespondentsAbbreviation: NS, not significant.Detailed Characteristics of the Respondents by CountryThe prevalence of skin changes ranged from 16.2% in Russia to 28% in Brazil. Women were more likely than men to report a change in their skin condition (24.7% vs 16.6%, respectively, p<0.00001). There was a positive correlation between the age and skin complaints (Spearman’s rho r=0.202, p<0.01). Drier skin was the main complaint in all five countries. Overall, the three main reported complaints during containment were drier skin (44.5%), skin rash (29.3%), and greasier skin (27%). Women were more likely than men to report drier skin (48.4% vs 37.9%, respectively, p=0.0007) and skin rash (31.7% vs 25.4%, respectively, p=0.0007).A total of 40.9% of the men (n=2246) and 50.2% of the women (n=2817) reported having a “sensitive” skin (Table 1). The difference between the 2 sexes was significant (p < 0.001).Among those, 20.9% (n=1500) reported a modification of their skin in relation to containment.Patients with sensitive skin were more likely to report skin changes during containment (27.7% vs 14.8%, p<0.00001). The difference was significant for both sexes (p<0.00001). Patients with sensitive skin were more likely to report skin rash, itch and redness (Table 1).Our study shows that women and individuals who reported sensitive skin perceived that containment was responsible for their subjective skin changes. In the current context, dryness of the skin, exacerbation of pruritus and rashes may be attributed to frequent use of soap and/or hydroalcoholic solutions, as well as to the use of facial masks outside of home.13–15 Stress of containment and uncertainty of the global situation, as well as an exacerbation of preexisting dermatoses, cannot be excluded. Geographic and seasonal climatic variations, as well as the way of life, may also have an impact. The limitations of our study include the declarative nature of the responses. In daily practice, dermatologists must integrate the notion of containment in the anamnesis over the next months as a possible clue to cutaneous symptoms.
Authors: M-A Richard; F Corgibet; M Beylot-Barry; A Barbaud; C Bodemer; V Chaussade; M D'Incan; P Joly; M T Leccia; J M Meurant; A Petit; B Roy Geffroy; J F Sei; C Taieb; L Misery; K Ezzedine Journal: J Eur Acad Dermatol Venereol Date: 2018-07-16 Impact factor: 6.166
Authors: Anne Guertler; Nicholas Moellhoff; Thilo L Schenck; Christine S Hagen; Benjamin Kendziora; Riccardo E Giunta; Lars E French; Markus Reinholz Journal: Contact Dermatitis Date: 2020-06-16 Impact factor: 6.419